Bevacizumab as a treatment option for radiation necrosis after cranial radiation therapy: a retrospective monocentric analysis.

Raphael BodensohnI HadiD F FleischmannS CorradiniN ThonJ RauchC BelkaM Niyazi

Published in: Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] (2019)

BEV might be an effective and safe therapeutic option for patients with radiation necrosis as a complication after cranial radiation therapy. Patients seem to benefit from this treatment by improving symptomatically or through reduction of dexamethasone.

Keyphrases

radiation therapy
end stage renal disease
radiation induced
chronic kidney disease
newly diagnosed
ejection fraction
low dose
combination therapy
prognostic factors
rectal cancer